Dimitrios Tsiachris | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Assist. Prof. Dr. Dimitrios Tsiachris | Medicine | Best Researcher Award

EP and Pacing Lab Director | National and Kapodestrian University of Athens | Greece

Dr. D. L. Tsiachris is a highly accomplished cardiovascular researcher and clinician whose work has profoundly influenced the fields of cardiac electrophysiology and interventional cardiology. With an extensive research portfolio encompassing 224 scientific publications, 4,004 citations, and a Scopus h-index of 34, his contributions have advanced the understanding and management of complex cardiac rhythm disorders. His primary research interests lie in atrial fibrillation, ventricular arrhythmias, catheter ablation, and cardiac resynchronization therapy, with particular emphasis on novel energy-based interventions such as pulsed field ablation, cryoballoon technology, and radiofrequency systems. Dr. Tsiachris possesses exceptional research skills in clinical trial design, data synthesis, systematic reviews, and meta-analysis, enabling him to provide robust evidence supporting safer and more effective therapeutic strategies for patients with structural and electrical heart diseases. His investigations into leadless pacing systems, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, and the optimization of device-based therapies have contributed to personalized and precision-based cardiology. In addition, his studies on patient-reported outcomes and long-term ablation success rates bridge the gap between procedural innovation and patient-centered care. Recognized for his scientific leadership and collaborative excellence, Dr. Tsiachris has co-authored with more than 700 international researchers and continues to influence clinical practice guidelines through his impactful findings. Though his work is primarily published in high-impact journals such as Heart Rhythm, Europace, and Journal of Clinical Medicine, his commitment to advancing cardiovascular science stands as his greatest distinction. Honored for his research excellence and global contributions to electrophysiology, Dr. D. L. Tsiachris remains a driving force in redefining the standards of modern cardiac care through innovation, precision, and evidence-based practice.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Gatzoulis, K. A., Tsiachris, D., Arsenos, P., et al. (2019). Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study. European Heart Journal, 40(35), 2940–2949.

Gatzoulis, K. A., Vouliotis, A. I., Tsiachris, D., et al. (2013). Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: Reappraisal of the role of programmed ventricular stimulation. Circulation: Arrhythmia and Electrophysiology, 6(3), 504–512.

Gatzoulis, K. A., Tsiachris, D., et al. (2018). Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy. International Journal of Cardiology, 254, 175–181.

Silberbauer, J., Tsiachris, D., et al. (2014). Noninducibility and late potential abolition: A novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circulation: Arrhythmia and Electrophysiology, 7(3), 424–435.

Della Bella, P., Tsiachris, D., et al. (2013). Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation. Circulation, 127(13), 1359–1368.

Dr. Mokgata A. Matjie’s research advances human resource and organizational management by promoting fairness, emotional intelligence, and performance excellence. His work strengthens institutional effectiveness, employee well-being, and leadership accountability—driving innovation in workplace culture and public sector transformation globally.

Manouchehr Ashrafpour | Medicine | Best Scholar Award

Published on by Scientific World Research Awards

Dr. Manouchehr Ashrafpour | Medicine | Best Scholar Award

Faculty Member | Babol University of Medical Sciences | Iran

Dr. Manouchehr Ashrafpour is a prominent neuroscientist and biomedical researcher at Babol University of Medical Sciences, renowned for his extensive contributions to neuropharmacology, molecular neuroscience, and neurodegenerative disease research. He earned his advanced degrees in medical sciences and neuroscience, building a strong academic foundation that bridges cellular biology and clinical neurotherapeutics. Throughout his professional career, Dr. Ashrafpour has demonstrated exceptional expertise in experimental neurobiology, drug delivery systems, and the molecular mechanisms underlying brain disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and multiple sclerosis. His research primarily focuses on the neuroprotective effects of natural bioactive compounds and nanotechnology-based formulations, including curcumin-, piperine-, arbutin-, and quercetin-loaded nanoparticles, which have shown promising results in reducing oxidative stress, glial activation, and neuronal degeneration. He possesses advanced research skills in animal modeling, histopathological assessment, biochemical analysis, neurobehavioral testing, and nanomedicine formulation, complemented by a strong command of cellular electrophysiology and molecular signaling studies. His professional experience encompasses collaborations with leading neuroscientists on projects exploring the role of vitamins, antioxidants, and receptor modulation (notably adenosine A2A receptor blockade) in promoting neural repair and functional recovery. Dr. Ashrafpour’s scholarly achievements are reflected in his strong Scopus record, which includes over 700 citations, numerous peer-reviewed documents, and an h-index of 17, underscoring his global academic influence. He has received recognition and academic honors for his innovative work in neurotherapeutic discovery and translational neuroscience, highlighting his commitment to improving treatment strategies for neurodegenerative diseases. In conclusion, Dr. Manouchehr Ashrafpour stands as a distinguished figure in contemporary neuroscience, whose multidisciplinary approach—spanning nanotechnology, pharmacology, and neurobiology—continues to shape the future of neuroprotective medicine and inspire emerging researchers in biomedical sciences worldwide.

Profiles: ORCID | Google Scholar 

Featured Publications

  1. Naeimi, R., Safarpour, F., Hashemian, M., Tashakorian, H., Ahmadian, S. R., & Ashrafpour, M. (2018). Curcumin-loaded nanoparticles ameliorate glial activation and improve myelin repair in lyolecithin-induced focal demyelination model of rat corpus callosum. Neuroscience Letters, 674, 1–10. Cited by 71.

  2. Mansoor, S. R., Hashemian, M., Khalili-Fomeshi, M., Ashrafpour, M., & Moghadamnia, A. A. (2018). Upregulation of klotho and erythropoietin contributes to the neuroprotection induced by curcumin-loaded nanoparticles in an experimental model of chronic epilepsy. Brain Research Bulletin, 142, 281–288. Cited by 52.

  3. Khalili-Fomeshi, M., Azizi, M. G., Esmaeili, M. R., Gol, M., Kazemi, S., & Ashrafpour, M. (2018). Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus. Behavioural Brain Research, 337, 131–138. Cited by 49.

  4. Dastan, Z., Pouramir, M., Ghasemi-Kasman, M., Ghasemzadeh, Z., Dadgar, M., & Ashrafpour, M. (2019). Arbutin reduces cognitive deficit and oxidative stress in an animal model of Alzheimer’s disease. International Journal of Neuroscience, 129(11), 1145–1153. Cited by 45.

  5. Dadgar, M., Pouramir, M., Dastan, Z., Ghasemi-Kasman, M., & Ashrafpour, M. (2018). Arbutin attenuates behavioral impairment and oxidative stress in an animal model of Parkinson’s disease. Avicenna Journal of Phytomedicine, 8(6), 533–540. Cited by 43.

 

 

Nasser Mousa | Public Health | Best Researcher Award

Published on by Scientific World Research Awards

Prof. Dr. Nasser Mousa | Public Health | Best Paper Award

Professor | Mansoura University | Egypt

Prof. Dr. Nasser Hamed Mousa is a renowned Egyptian medical scientist and hepatologist, serving at the Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt. With a Scopus record of 1,028 citations, 47 scientific publications, and an h-index of 16, he has made exceptional contributions to the fields of hepatology, gastroenterology, metabolic diseases, and translational medicine. Prof. Mousa earned his M.B.B.Ch., M.Sc., and Ph.D. in Hepatology and Gastroenterology from leading Egyptian medical universities, where he developed a strong foundation in internal medicine and liver pathology. Over the years, he has built an impressive professional career focusing on clinical hepatology, particularly viral hepatitis, liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). His research interests encompass liver disease surveillance, nanomedicine, cancer biology, and metabolic dysfunction-associated steatotic liver disease (MASLD). Notably, his recent studies on individualized HCC risk stratification and gold nanoparticle-mediated cancer therapy have gained international recognition for their innovative clinical and molecular insights. Prof. Mousa’s research skills span molecular diagnostics, clinical trial design, bioinformatics-based network pharmacology, and predictive modeling for liver disease outcomes, reflecting his multidisciplinary expertise. His collaboration with national and international research teams underscores his leadership in evidence-based hepatology. Prof. Mousa has also contributed to advancing precision medicine approaches for patients with chronic liver disease, integrating laboratory science with clinical decision-making. Throughout his career, he has received numerous academic honors and institutional recognitions for his excellence in research, publication impact, and contribution to medical innovation. In conclusion, Prof. Dr. Nasser Hamed Mousa stands as a distinguished figure in liver research, embodying excellence in scientific inquiry, clinical innovation, and academic leadership, while his impactful body of work continues to influence global hepatology and improve patient outcomes in Egypt and worldwide.

Profiles: Scopus | ORCID 

Featured Publications

  1. Mousa, N., Elbaz, S., Elmetwalli, A., Mansour, M., Abdelsalam, M., Abdelaziz, M., Hashem, M., El-Emam, O., El-wakeel, N., Elgamal, A., et al. (2025). A risk stratification score for predicting first episode of upper gastrointestinal bleeding in patients with cirrhosis. Archives of Medical Research.

  2. Mousa, N., Elmetwalli, A., Abdel-Razik, A., Mousa, E., Abdelsalam, M., Elbaz, S., El-wakeel, N., Eldars, W., Gad, E., Arafa, M., et al. (2025, September 15). Periodontitis and metabolic dysfunction-associated steatotic liver disease: Emphasizing the clinical interplay between hepatologists and dentists. Odontology.

  3. Mousa, N., Elbaz, S., Elmetwalli, A., Abdelsalam, M., Abdelkader, E., Wahba, M., Abdelaziz, M., El-Emam, O., El-wakeel, N., Shaheen, M., et al. (2025, April 16). Neutrophil percentage-to-albumin ratio as a predictor of acute kidney injury in cirrhotic patients: A novel approach utilizing artificial intelligence. American Journal of Nephrology.

  4. Shiha, G., Mousa, N., Soliman, R., Mikhail, N. N. H., Elbasiony, M. A., & Khattab, M. (2020, July). Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study. Journal of Viral Hepatitis.

  5. Elbaz, S., Mousa, N., Besheer, T., Sheta, T., Taha, K., Awad, M., Effat, N., Elgamal, A., & Abdel-Razik, A. (2020, April 2). Malondialdehyde and C-reactive protein as prognostic markers of hepatocellular carcinoma. British Journal of Biomedical Science.

 

Jack Ng Kok Wah | Public Health | Best Researcher Award | 1653

Published on by Scientific World Research Awards

Dr. Jack Ng Kok Wah | Public Health | Best Researcher Award

Senior Lecturer | Multimedia University Cyberjaya | Malaysia

Dr. Jack Ng Kok Wah is an accomplished academic and industry professional with more than three decades of experience across healthcare, banking, education, and marketing, establishing himself as a well-rounded leader in both practice and scholarship. He earned his Ph.D. in Business in 2023 from Universiti Malaya-Wales, where his research explored psychological factors influencing health protective behavior among private healthcare consumers and the mediating role of consumer innovativeness, integrating behavioral science with health and marketing. His academic foundation also includes an MBA in Marketing from Olympia College Kuala Lumpur (2004) and a BA (Hons) in Marketing Management from Stamford College, Petaling Jaya (2001). Professionally, Dr. Jack has served as Marketing Manager in leading organizations such as Sentosa Specialist Hospital Klang, Tung Shin Hospital, Columbia Leisure Group, AmBank, and CIMB Bank, where he specialized in marketing management, digital innovation, and strategic leadership. Transitioning into academia, he is now a Senior Lecturer at Multimedia University, Cyberjaya, Malaysia, where he combines industry expertise with academic rigor to guide future professionals. His research interests encompass digital marketing, consumer behavior, artificial intelligence in healthcare, marketing psychology, and the emerging role of robotics in surgery and e-health solutions. He has published in reputed Scopus- and IEEE-indexed journals, including Frontiers in Public Health, Journal of Robotic Surgery, Food Reviews International, and Journal of Cases on Information Technology, contributing to multidisciplinary areas such as AI-driven healthcare, robotic surgery, fintech, digital learning, and workplace mental health. His research skills include advanced methodologies such as structural equation modeling, digital behavioral analytics, and systematic literature reviews, paired with the ability to link theory to applied practice. He also serves as a peer reviewer for international journals, reflecting his scholarly engagement. Dr. Jack holds the PIKOM Project Leadership Certification (PLC) Associate from the National ICT Association of Malaysia and is active on platforms like Scopus, ResearcherID, and ResearchGate, which strengthen his global visibility. With 25 citations across 10 indexed documents and an h-index of 3, he demonstrates promising research impact for a scholar who entered academia after a successful professional career. In conclusion, Dr. Jack Ng Kok Wah represents a unique blend of industry excellence, academic achievement, and research innovation, making him a strong candidate for honors such as the Best Researcher Award, as his work continues to advance knowledge while delivering meaningful societal impact.

Profiles: Scopus | ORCID | Google Scholar 

Featured Publications

  1. Wah, J.N.K. (2025). Revolutionizing surgery: AI and robotics for precision, risk reduction, and innovation. Journal of Robotic Surgery, 19(1), Article 47.

  2. Wah, J.N.K. (2025). The rise of robotics and AI-assisted surgery in modern healthcare. Journal of Robotic Surgery, 19(1), 311.

  3. Wah, J.N.K. (2025). AI-driven robotic surgery in oncology: Advancing precision, personalization, and patient outcomes. Journal of Robotic Surgery, 19(1), 1–11.

  4. Wah, J.N.K. (2025). Revolutionizing e-Health: The transformative role of AI-powered hybrid chatbots in healthcare solutions. Frontiers in Public Health, 13, Article 1530799.

  5. Ng, J., Wah, K., Fitriana, M., & Arumugam, T. (2023). Assumptions for structure equation modeling (SEM), normality of data distribution analysis & model fit measures. Journal of Clinical Epidemiology & Toxicology, 4(2), 1–5.